These results were observed in the test subjects regardless of whether the peptide was administered orally or subcutaneously
But if you're thinking like much of the media suggests that GLP1s are gonna be a panacea for mental health, Santa has brought some bad news this Christmas recently, the GLP1s disappointed in several neuropsychiatric outcomes, in a randomized trial of major depression, failing to reduce depression or improve cognition in the first randomized trial to test that use, and failing to prevent cognitive decline in two large, industry-sponsored trials of dementia
Mounjaro is only available as a prefilled injection pen
The safety profile was statistically indistinguishable from placebo across all trials
Tirzepatide starts at 2.5 mg weekly, increasing to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and potentially 15 mg
For more travel-specific tips, our guide on managing GLP-1 medication while traveling covers the essentials